Epstein Secrets

ording to "an email obtained by ABC News, the bulletin was supposed to go out on July 9, but it never did. The Chief of Staff to Acting Secretary of Homeland Security Chad Wolf put the brakes on, writing, `Please hold on sending this one out until you have a chance to speak to AS1.' AS1 is Acting Secretary Wolf.

https://www.nytimes.corn/2020/09/02/opinion/coronavirus-convalescent-plasma.html> (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate evidence." Lamas writes that possible treatments must undergo clinical tria

rding to "an email obtained by ABC News, the bulletin was supposed to go out on July 9, but it never did. The Chief of Staff to Acting Secretary of Homeland Security Chad Wolf put the brakes on, writing, `Please hold on sending this one out until you have a chance to speak to AS1.' AS1 is Acting Secretary Wolf. T

or Efficacy Or Safety Of Convalescent Plasma. In an op-ed for the New York Times (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate evidence." Lamas writes that possible treatments must undergo clinical tria

rding to "an email obtained by ABC News, the bulletin was supposed to go out on July 9, but it never did. The Chief of Staff to Acting Secretary of Homeland Security Chad Wolf put the brakes on, writing, 'Please hold on sending this one out until you have a chance to speak to AS1.' AS1 is Acting Secretary Wolf. T

or Efficacy Or Safety Of Convalescent Plasma. In an op-ed for the New York Times (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate evidence." Lamas writes that possible treatments must undergo clinical tria